Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Tenofovir is not associated with renal dysfunction following solid organ transplantation

Go back to Resources

Tenofovir is not associated with renal dysfunction following solid organ transplantation

Authors:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration

Go back to Resources

Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia

Go back to Resources

Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Predictors of Serological Cure and Serofast State After Treatment in HIV-Negative Persons With Early Syphilis

Go back to Resources

Predictors of Serological Cure and Serofast State After Treatment in HIV-Negative Persons With Early Syphilis

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Persistent Environmental Pollutants and Couple Fecundity, The LIFE Study

Go back to Resources

Persistent Environmental Pollutants and Couple Fecundity, The LIFE Study

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Go back to Resources

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

Authors:

Location:

URL:

Go back to Resources

Joint Models

Go back to Resources

Joint Models

Authors:

Secondary:

Pagination:

Location:

Publisher:

URL:

Keywords:

Abstract:

Go back to Resources

Incentives and barriers to neurological clinical research participation

Go back to Resources

Incentives and barriers to neurological clinical research participation

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

HLA Class I Sensitization in Islet Transplant Recipients - Report from The Collaborative Islet Transplant Registry

Go back to Resources

HLA Class I Sensitization in Islet Transplant Recipients - Report from The Collaborative Islet Transplant Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

HIV-Related Predictors and Outcomes in 275 Liver and/or Kidney Transplant Recipients (oral presentation)

Go back to Resources

HIV-Related Predictors and Outcomes in 275 Liver and/or Kidney Transplant Recipients (oral presentation)

Authors:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 197
  • Page 198
  • Page 199
  • Page 200
  • Current page 201
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification